Skip to main content
IMMUPHARMA PLC logo

IMMUPHARMA PLC — Investor Relations & Filings

Ticker · IMM ISIN · GB0033711010 LEI · 213800VZKGHXC7VUS895 IL Professional, scientific and technical activities
Open in API
Filings indexed 443 across all filing types
Latest filing 2018-12-31 Regulatory Filings
Country GB United Kingdom
Listing IL IMM

About IMMUPHARMA PLC

https://www.immupharma.co.uk/

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Recent filings

Filing Released Lang Actions
Clinical Development Collaboration with Incanthera
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 31 December 2018. It provides an 'UPDATE ON NUCANT CANCER PROGRAMME' and discusses an extension to a 'Definitive Licence Agreement' between ImmuPharma PLC and Incanthera Limited. The text concludes with a standard disclaimer stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure is characteristic of a general regulatory news service announcement, which fits the definition of Regulatory Filings (RNS), as it is a broad announcement of company activity not specifically covered by other detailed categories like ER, 10-K, or DIV. Given the short length and the nature of the update, RNS is the most appropriate classification.
2018-12-31 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1499 characters) and contains an 'RNS Number' and mentions the 'London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement made via the Regulatory News Service (RNS). Since this is a general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV), and it is explicitly delivered via RNS, the most appropriate classification is the general regulatory filing category.
2018-12-21 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1482 characters) and contains an 'RNS Number' header, indicating it is a regulatory news service announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' and an 'auction call extension' for a security. This type of operational market announcement, which does not fit into specific financial reporting categories (like 10-K, ER, or IR), is best classified under the general regulatory announcement category, RNS, as per the definitions and the 'Menu vs Meal' rule (it's an announcement, not a full report).
2018-12-21 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1482 characters) and contains an RNS Number, indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' and an 'auction call period extension' for a security, which is a specific type of market operation update. This type of miscellaneous, non-standard regulatory update that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory announcement category, RNS (Regulatory Filings), as per the definitions and the 'Menu vs Meal' rule (it's an announcement, not a full report).
2018-12-20 English
Appointment of Nominated Adviser
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content announces the 'APPOINTMENT OF NOMINATED ADVISOR' (SPARK Advisory Partners Limited) and includes contact details for brokers and the NOMAD. This is a general regulatory announcement that does not fit into specific financial reporting categories like 10-K, ER, or IR. Since it is a general regulatory announcement distributed via the RNS system, the most appropriate classification is Regulatory Filings (RNS). The document length is short (2812 chars), but the content is the announcement itself, not an announcement *about* another report, making RNS more suitable than RPA.
2018-12-17 English
Update on Corporate Activities
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date '07 December 2018', indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content provides an 'UPDATE ON CORPORATE ACTIVITIES' covering several operational aspects (Lupuzor MAP progress, Nucant collaboration, Ureka divestment review, and NOMAD change). This is a general update on company activities and progress, not a specific financial report (like 10-K or IR), a formal earnings release (ER), or a proxy statement. Since it is a general regulatory announcement that updates the market on various ongoing corporate matters and is explicitly distributed via RNS, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements not covered by more specific codes. The document length (6484 chars) is substantial enough that it is not just a brief announcement of a report (RPA), but the report/update itself.
2018-12-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.